General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
How the counterfeit bill can negatively affect access to medicines in Uganda
Uganda largely depends on generic medication to treat the sick, but a new Counterfeit Bill may put a stop to the cheaper drugs.
ASEAN ministers sign drug accord
ASEAN Economic Ministers sign deal on safety, quality, efficacy and lower prices of drugs sold in the region - Philippine Daily Inquirer
Edinburgh to be the first British university to help make medicines cheaper in developing world
Edinburgh will be the first British university to license research to pharmaceutical companies only on condition that poorer communities get life-saving drugs at cost price.
Malaria drugs cheaper in £150m deal to save lives
Up to 300,000 lives a year could be saved by a groundbreaking international deal that will slash the cost of medicines to fight malaria - The Guardian, UK
Merck follows up GSK challenge by donating malaria drug to non-profit group
Merck is donating an experimental anti-malarial medicine to a not-for-profit research organisation - Reuters
Decline in government financial transparency in the Philippines
The Open Budget Survey 2008, ranks the Philippines 34th and has a two point drop in the index used to measure transparency from when the survey was conducted two years ago.
Need for increased transparency in medicine regulation processes
Full transparency is needed for all steps in medicines' marketing, from the publication of trial protocols, to assessment of the data - Australian Prescriber editorial.
Medical school students in the US raise concerns about promotion
Students at Yale are calling for greater transparency and enforcement of conflict of interest guidelines to minimise pharmaceutical companies’ influence on education.
Novartis supports access to medicines in the Philippines
Novartis to look at ways to "improve patient access to breakthrough medicines, preventive vaccines and diagnostics, over-the-counter medicines and high-quality generics".
GlaxoSmithKline announces price cuts and patent sharing
GlaxoSmithKline will share more than 800 drug patents with others hunting new cures for neglected tropical diseases and reduce the price of more than 110 medicines - Reuters.